Clinical trial attempts to cure autism
Researchers recently announced the beginning of a FDA-approved clinical trial that uses umbilical cord blood stem cells to ‘cure’ autism.
Dr. Michael Chez, director of pediatric neurology at Sutter Neuroscience Institute in Sacramento, Calif., said he and his colleagues have been processing the trial for more than a year now, and they have high hopes it will succeed.
“What we are looking at, is cases that don’t have an obvious genetic link,” Chez told FoxNews.com. “Patients that we presume something went wrong with their brains, which caused a change to autistic features.”
In other words, the trial’s patients will essentially have no reason to have autism – or at least no genetic markers for the disease. This means they must have presumably developed it through another factor, such as the environment or exposure to an infection.